Smallpox Research Activities: U.S. Interagency Collaboration, 2001

Autor: Inger K. Damon, James W. LeDuc, Peter B. Jahrling, David A. Relman, John W. Huggins, J M Meegan
Rok vydání: 2002
Předmět:
Microbiology (medical)
medicine.medical_specialty
bioterrorism
Epidemiology
viruses
Advisory committee
Drug Evaluation
Preclinical
lcsh:Medicine
Select committee
World Health Organization
Antiviral Agents
complex mixtures
World health
lcsh:Infectious and parasitic diseases
chemistry.chemical_compound
vaccine
Animals
Humans
Medicine
Smallpox
lcsh:RC109-216
Smallpox vaccine
vaccinia
business.industry
Research
lcsh:R
Genetic Variation
virus diseases
Variola virus
medicine.disease
Virology
Weapon of mass destruction
United States
orthopoxviruses
smallpox
Disease Models
Animal
Macaca fascicularis
Interinstitutional Relations
Infectious Diseases
National Institutes of Health (U.S.)
chemistry
Family medicine
News and Notes
Centers for Disease Control and Prevention
U.S
Vaccinia
business
Smallpox Vaccine
Zdroj: Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 8, Iss 7, Pp 743-745 (2002)
ISSN: 1080-6059
1080-6040
Popis: For the past 2 years, a team of investigators from the Centers for Disease Control and Prevention (CDC) has collaborated with scientists from the National Institutes of Health (NIH), the Food and Drug Administration, the Department of Defense (DOD), academic centers, and international partners to undertake a research agenda on variola virus, the etiologic agent of smallpox. Objectives of the program derive from a 1999 Institute of Medicine report that addressed the scientific needs for live variola virus (1). Progress in addressing these objectives has been peer reviewed annually by both a select committee organized by CDC and the World Health Organization (WHO) Advisory Committee on Variola Virus Research (2,3). A summary of accomplishments from the first year’s efforts was published in 2001 (4). The events of September 11, 2001, coupled with the use of Bacillus anthracis as a bioterrorist weapon of mass destruction, have substantially increased concerns that variola virus may be similarly used and have added a sense of urgency to production of a new smallpox vaccine and to carrying out the smallpox research agenda. This report provides an update on progress during 2001.
Databáze: OpenAIRE
Externí odkaz: